BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15015590)

  • 1. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
    Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
    Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
    Mhawech P; Kinkel K; Vlastos G; Pelte MF
    Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
    Canet B; Pons C; Espinosa I; Prat J
    Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of p53 mutation in the carcinomas arising from endometriosis.
    Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
    Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor II: to a link between endometriosis and endometrioid ovarian cancer.
    Keita M; AinMelk Y; Pelmus M; Bessette P; Aris A
    J Obstet Gynaecol Res; 2011 Feb; 37(2):99-107. PubMed ID: 21083841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
    Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
    Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
    Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
    Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
    Munksgaard PS; Blaakaer J
    Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
    Jiang X; Morland SJ; Hitchcock A; Thomas EJ; Campbell IG
    Cancer Res; 1998 Apr; 58(8):1707-12. PubMed ID: 9563487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma arising in extragonadal endometriosis: an immunohistochemical study.
    Han AC; Hovenden S; Rosenblum NG; Salazar H
    Cancer; 1998 Sep; 83(6):1163-9. PubMed ID: 9740081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrioid adenocarcinoma of the ovary and endometriosis.
    Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
    Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
    Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
    Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
    Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [bcl-2 and p53 protein expressions in the malignant transformation of ovarian endometriosis].
    Qian J; Shi Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):403-5. PubMed ID: 11810773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell carcinoma and endometrioid carcinoma arising in a endometriotic cyst of the ovary.
    Tohya T; Shibata S; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1111-4. PubMed ID: 3746029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
    Chew S; Tham KF; Ratnam SS
    Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
    Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
    Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic defects in endometriosis.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.